Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

324 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
No socioeconomic inequalities in ovarian cancer survival within two randomised clinical trials.
Abdel-Rahman ME, Butler J, Sydes MR, Parmar MK, Gordon E, Harper P, Williams C, Crook A, Sandercock J, Swart AM, Rachet B, Coleman MP; ICON2 and ICON3 investigators. Abdel-Rahman ME, et al. Among authors: parmar mk. Br J Cancer. 2014 Jul 29;111(3):589-97. doi: 10.1038/bjc.2014.303. Epub 2014 Jun 10. Br J Cancer. 2014. PMID: 24918817 Free PMC article.
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.
Parmar MK, Ledermann JA, Colombo N, du Bois A, Delaloye JF, Kristensen GB, Wheeler S, Swart AM, Qian W, Torri V, Floriani I, Jayson G, Lamont A, Tropé C; ICON and AGO Collaborators. Parmar MK, et al. Lancet. 2003 Jun 21;361(9375):2099-106. doi: 10.1016/s0140-6736(03)13718-x. Lancet. 2003. PMID: 12826431 Clinical Trial.
Paclitaxel and cisplatin in ovarian cancer.
Torri V, Harper PG, Colombo N, Sandercock J, Parmar MK. Torri V, et al. Among authors: parmar mk. J Clin Oncol. 2000 Jun;18(11):2349-51. J Clin Oncol. 2000. PMID: 10829060 No abstract available.
Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: a meta-analysis using individual patient data.
Raja FA, Counsell N, Colombo N, Pfisterer J, du Bois A, Parmar MK, Vergote IB, Gonzalez-Martin A, Alberts DS, Plante M, Torri V, Ledermann JA. Raja FA, et al. Among authors: parmar mk. Ann Oncol. 2013 Dec;24(12):3028-34. doi: 10.1093/annonc/mdt406. Epub 2013 Nov 4. Ann Oncol. 2013. PMID: 24190964 Free article. Review.
Chemotherapy for ovarian cancer.
Parmar MK, Sandercock J. Parmar MK, et al. N Engl J Med. 1996 May 9;334(19):1268-9; author reply 1270. doi: 10.1056/NEJM199605093341912. N Engl J Med. 1996. PMID: 8606729 Free article. No abstract available.
Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data.
Mauguen A, Pignon JP, Burdett S, Domerg C, Fisher D, Paulus R, Mandrekar SJ, Belani CP, Shepherd FA, Eisen T, Pang H, Collette L, Sause WT, Dahlberg SE, Crawford J, O'Brien M, Schild SE, Parmar M, Tierney JF, Le Pechoux C, Michiels S; Surrogate Lung Project Collaborative Group. Mauguen A, et al. Lancet Oncol. 2013 Jun;14(7):619-26. doi: 10.1016/S1470-2045(13)70158-X. Epub 2013 May 14. Lancet Oncol. 2013. PMID: 23680111 Free PMC article.
324 results